Polyclonal mixture of physiological antigens and Fcγ receptors on immune cells

The target "Polyclonal mixture of physiological antigens and Fcγ receptors on immune cells" refers to the collective set of molecular entities interacted with by Intravenous Immunoglobulin (IVIG) and related therapeutic antibody preparations. This complex target system includes the various classes of Fc gamma receptors (FcγRI, FcγRII, and FcγRIII) found on immune effector cells, as well as a diverse array of physiological antigens such as pro-inflammatory cytokines, complement proteins, and the idiotypic regions of endogenous autoantibodies. By engaging these targets, IVIG exerts a multi-modal immunomodulatory effect, which includes blocking activating Fc receptors, inducing inhibitory signaling through FcγRIIB, and neutralizing circulating inflammatory mediators. This system plays a pivotal role in the management of numerous autoimmune and inflammatory conditions, including immune thrombocytopenia (ITP), Kawasaki disease, and chronic inflammatory demyelinating polyneuropathy (CIDP). The therapeutic success of targeting this system is attributed to the broad-spectrum regulatory capacity of the polyclonal IgG pool, which helps restore immune homeostasis in patients with dysregulated immune responses.

Other names

Fc gamma receptors (FcγR)Physiological antigensIVIG targetsNormal human immunoglobulin targetsImmune complex receptorsFc receptors and autoantigens

Modulation of Fcγ receptor signaling (blocking activating receptors and upregulating inhibitory FcγRIIB) and neutralization of physiological antigens including cytokines, complement components, and autoantibodies via anti-idiotypic interactions.